key: cord-0863895-t3v87u3m authors: RIBEIRO-JUNIOR, Marcelo Augusto Fontenelle; AUGUSTO, Samara de Souza; ELIAS, Yasmin Garcia Batista; COSTA, Cássia Tiemi Kawase; NÉDER, Paola Rezende title: GASTROINTESTINAL COMPLICATIONS OF CORONAVIRUS DISEASE (COVID-19) date: 2021-12-17 journal: Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery DOI: 10.1590/0102-672020210002e1620 sha: 897700aad0c0cbbb37e5053e1c9608fda90a46e5 doc_id: 863895 cord_uid: t3v87u3m BACKGROUND: It is currently understood that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) directly enters target cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor. Accordingly, tissues with high expression levels of ACE2 are more susceptible to infection, including pulmonary alveolar epithelial cells, small intestine enterocytes, cholangiocytes, and vascular endothelial cells. Considering the atypical manifestations of COVID-19 and the challenges of early diagnosis, this review addresses the possible gastrointestinal complications of the disease. METHOD: The phrase “Gastrointestinal complication of COVID” was searched in the PubMed, Medline, and SciELO databases. Due to the heterogeneity of the studies included in the present review, a narrative synthesis of the available qualitative data was performed. RESULT: The literature search retrieved 28 articles, primarily case reports and case series, for the qualitative analysis of gastrointestinal complications of COVID-19, in addition to two retrospective cohort and one case-control. The studies focused on hemorrhagic, thrombotic, ischemic, and perforation complications, in addition to acute pancreatitis and pneumatosis intestinalis. CONCLUSION: There is a straight relationship between high expression levels of ACE2 in the gastrointestinal tract and its greater susceptibility to direct infection by SARS-CoV-2. So, it is important to consider the gastrointestinal infection manifestations for early diagnosis and treatment trying to avoid more serious complications and death. Organization declared a public health emergency of international concern, described as a pandemic, on March 11, 2020 47 . As of early January 2021, Johns Hopkins University (Baltimore, MD, USA) confirmed 92,240,036 cases globally, of which 1,975,707 were fatal 17 . Since September 2020, the world has witnessed a "second wave" of COVID-19, associated not only with an increase in the number of cases, but also with the emergence of new SARS-CoV-2 variants 12, 15 . The primary symptoms of COVID-19 include fever, dry cough, dyspnea, fatigue, myalgia, and headache 45 . Although poorly related to the disease, extrapulmonary symptoms have also been documented since the beginning of the pandemic, with gastrointestinal symptoms being the most relevant. Some patients experience gastrointestinal manifestations in the early stages of the disease, including nausea, vomiting, diarrhea, abdominal pain, and anorexia 8, 28, 31, 37, 45 . While others progress without exhibiting any respiratory symptoms 16, 20, 41 . It is currently understood that SARS-CoV-2 can directly infect target cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor. Accordingly, tissues with high expression levels of this receptor are more susceptible to infection. Tissues with higher receptor concentrations include pulmonary alveolar epithelial cells, small intestine enterocytes, cholangiocytes, and vascular endothelial cells 1, 8, 18, 20, 31, 38, 46 . ACE2 acts to regulate the inflammatory response, and its distribution in abdominal organs possibly explains the extrapulmonary symptoms experienced by some patients. Cellular alteration(s) result in intestinal and hepatic inflammation, as well as alteration(s) to the intestinal microbiota 1,21 . Furthermore, gastrointestinal and respiratory comorbidities can increase the severity of the disease. However, gastrointestinal symptoms can be underdiagnosed because they usually manifest in the early stages of disease and are self-limited, thus making it difficult to correlate them with a diagnosis of COVID-19 20 . Considering the atypical manifestations and challenges of early diagnosis, this review addresses possible gastrointestinal complications within the current context of the COVID-19 pandemic. A literature search of the PubMed, Medline, and SciELO databases was performed in November 2020 using the phrase "Gastrointestinal complication of COVID". The search was limited to articles published in English and Spanish, and filters for type of study or date were initially not used. The literature search retrieved 587 articles. After excluding 248 duplicate articles, 339 were analyzed with regard to title and abstract, with six excluded for incompatible dates (published before 2020) and 227 for focusing on other topics. Of the remaining 106 articles, 81 were excluded for not addressing complications, although they focused on gastrointestinal involvement in COVID-19. After a manual search of citations, an additional four articles were included for relevance. Ultimately, 29 articles were included in the present review ( Figure 1 ). Due to the heterogeneous nature of the studies included in this review, a narrative synthesis of the qualitative available data was performed. A total of 28 articles, primarily case reports and case series, were selected for a narrative synthesis of qualitative data addressing the gastrointestinal complications of COVID-19, in addition to two retrospective cohort studies and one case-control. The studies reported on hemorrhagic, thrombotic, ischemic, and perforation complications, in addition to acute pancreatitis and pneumatosis intestinalis [3] [4] [5] [6] [7] [9] [10] [11] 13, 14, 18, 19, [22] [23] [24] [25] [26] [27] 29, 30, [32] [33] [34] [35] [36] 40, 42, 44 . (Tables 1 to 5) Considering the atypical manifestations of COVID-19, primary care for patients experiencing extrapulmonary symptoms can be initiated without early diagnosis to avoid more serious complications when associated with respiratory conditions. Although gastrointestinal symptoms often present early and tend to evolve in the most severe forms of the disease, they are the only symptoms of the disease in some cases 20 . A case presented by Amarapurkar et al. 3 A retrospective study by Mauro et al. 33 Coagulation dysfunction is one of the main causes of death in patients with severe COVID-19, who are more likely to exhibit a state of hypercoagulability, with manifestations of intravascular coagulation due to local damage 10, 13 . Coagulopathy, high levels of D-dimer, and fibrinogen at the time of hospital admission for COVID-19 have been associated with a poorer clinical course, and higher risk for micro-and macro-circulatory thrombosis, and a higher mortality rate in hospitalized patients 6, 10 . The absence of important predisposing factors for thromboembolic formation in a patient who developed thrombosis in the superior mesenteric artery and acute intestinal ischemia suggested and reinforced the theory that there is a causal relationship between COVID-19 and hypercoagulability 10 . In a case reported by Correa Neto et al. 13 The management of these patients should include coagulation tests, including coagulation profile, platelet count and D-dimer levels, to help determine a prognosis and dosages of anticoagulant agents, and imaging studies for early diagnosis to increase the chances for survival 10, 40 . It is important to note that thrombolytic therapy should be used carefully, considering that such events can be self-limited, and that COVID-19 is also associated with thrombocytopenia and coagulopathy, with risk for developing widespread intravascular coagulation 26 . In addition, prophylaxis measures should be implemented during hospitalization and after discharge 40 . In another report, Ibrahim et al. 24 SARS-CoV-2 uses the ACE2 receptor to enter cells and the serine protease TMPRSS2 for protein S priming. These two proteins are highly co-ex- The gas can enter the intestinal wall due to the coexistence of increased intraluminal pressure, rupture of the mucosa, and increased permeability. In addition, the excessive production of hydrogen due to bacterial growth can lead to gas oversaturation, thereby overloading diffusion capacity in the bloodstream and, consequently, leading to the formation of cysts containing gas 34 . Considering the relationship between high expression levels of ACE2 in the gastrointestinal tract and its greater susceptibility to direct infection by SARS-CoV-2 is established, it is important to consider the various gastrointestinal manifestations and complications in these patients. The most important include gastrointestinal hemorrhage, thrombotic and ischemic events, perforation, pancreatitis and, less commonly, pneumatosis intestinalis. Therefore, when managing patients with known SARS-CoV-2 infection, or even initially without a diagnosis of COVID-19, all gastrointestinal manifestations should be considered, diagnosed, and treated early to prevent even more serious complications and death. Clinical insight into the involvement of gut and liver by COVID-19 COVID-19 presenting as acute pancreatitis Haemorrhagic enteritis and COVID-19: causality or coincidence Self-limited gastrointestinal bleeding in COVID-19 Report: Novel Coronavirus-A Potential Cause of Acute Pancreatitis? Coronavirus disease 2019 (COVID-19) and ischemic colitis: An underrecognized complication A severe coronavirus disease 2019 patient with high-risk predisposing factors died from massive gastrointestinal bleeding: a case report Gastrointestinal and liver manifestations of COVID-19 Recurrent Acute Pancreatitis in a Patient with COVID-19 Infection Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection Clinical and intestinal histopathological findings in SARS-CoV-2/COVID-19 patients with hematochezia The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem Perforated acute abdomen in a patient with COVID-19: an atypical manifestation of the disease Bowel perforation in a Covid-19 patient: case report The COVID-19 second wave: A perspective to be explored COVID-19 and gastrointestinal tract An interactive web-based dashboard to track COVID-19 in real time Lancet Infect Dis Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19 Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2 COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19 ? Uncommon presentation of COVID-19: Gastrointestinal bleeding Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19 Gastrointestinal perforation in a critically ill patient with COVID-19 pneumonia A case report on spontaneous hemoperitoneum in COVID-19 patient Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP) Gastrointestinal and liver manifestations in patients with COVID-19 Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection COVID-19 and the Digestive System Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy Pneumatosis intestinalis in COVID-19 Peptic Ulcer Disease as a Common Cause of Bleeding in Patients with Coronavirus Disease 2019 Intestinal perforation caused by COVID-19. ABCD Arq Bras Cir Dig Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Metaanalysis Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evolution Acute mesenteric thrombosis in two patients with COVID-19. Two cases report and literature review Covid-19 may present with acute abdominal pain SARS-CoV2 RNA detection in a pancreatic pseudocyst sample Undiagnosed pneumonia -China (Hubei): Request For Information Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review Covid-19 and the digestive system World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 WHO Statement regarding cluster of pneumonia cases in Wuhan, China